Market Research Logo

Uzbekistan Pharmaceuticals and Healthcare Report Q4 2017

Uzbekistan Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Uzbekistan's pharmaceutical market growth - the highest in local currency terms in 2016 for the Central and Eastern European (CEE) region - highlights opportunities for multinational drugmakers. Given the continued dependence on pharmaceutical imports, Uzbekistan's regional peers from the CIS States are well positioned to take advantage of the growth potential in the country's pharmaceutical market. However, the poor regulatory environment, with weak intellectual property protection, will limit the attractiveness to innovative drugmakers.

Headline Expenditure Projections

Pharmaceuticals: UZS3.19trn (USD956mn) in 2016 to UZS3.65trn (USD1.0bn) in 2017; 14.5% in local currency terms and 6.2% in US dollar terms. Forecast unchanged from the previous quarter.

Healthcare: UZS11.0trn (USD3.69bn) in 2016 to UZS12.6trn (USD3.50bn) in 2017; 14.7% in local currency terms and -5.6% in US dollar terms. Forecast unchanged from the previous quarter.

Risk/Reward Index

Uzbekistan's pharmaceutical market will continue to present severely limited opportunities for innovative drugmakers, reflected in its score of 38.1 in BMI's Innovative Pharmaceuticals Risk/Reward Index. This score ranks it 21st in the region. Demand for patented medicines will remain restricted by poor access to healthcare services, a young population and limited expenditure on medicines.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Uzbekistan 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Uzbekistan 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Uzbekistan 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Uzbekistan 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Uzbekistan 2015-2021)
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals: A Mixture Of Opportunities
Uzbekistan - Risk/Reward Index
Risks
Regulatory Review
Intellectual Property Issues
Pricing And Reimbursement Regime
Market Overview
Healthcare Sector
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Table: List Of Companies In Uzpharmsanoat SJSC (as of October 7 2013)
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Asklepiy Pharmaceutical Company
Jurabek Laboratories
Uzpharmsanoat
Demographic Forecast
Table: Population Headline Indicators (Uzbekistan 1990-2025)
Table: Key Population Ratios (Uzbekistan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Uzbekistan 1990-2025)
Table: Population By Age Group (Uzbekistan 1990-2025)
Table: Population By Age Group % (Uzbekistan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report